Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-25-030353
Filing Date
2025-03-03
Accepted
2025-03-03 06:02:39
Documents
4
Period of Report
2025-03-03

Document Format Files

Seq Description Document Type Size
1 6-K opt_-_opthea_phase_2b_we.htm 6-K 26214
2 PRESS RELEASE opt-ex99_1.htm EX-99.1 38247
3 GRAPHIC img260626642_0.jpg GRAPHIC 154802
4 GRAPHIC img260626642_1.jpg GRAPHIC 154802
  Complete submission text file 0000950170-25-030353.txt   492098
Mailing Address LEVEL 4 650 CHAPEL STREET SOUTH YARRA, VICTORIA C3 3141
Business Address LEVEL 4 650 CHAPEL STREET SOUTH YARRA, VICTORIA C3 3141 61 3 9826 0399
Opthea Ltd (Filer) CIK: 0001815620 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-39621 | Film No.: 25693514
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)